search
Back to results

TOP-mums, for a Healthy Start

Primary Purpose

Overweight, Obesity, Pregnancy Complications

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Lifestyle intervention
Sponsored by
Maastricht University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Overweight

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Women with a pregnancy wish within 1 year;
  • Aged 18-40 years;
  • Overweight/obesity (BMI ≥ 25 kg/m2).

Exclusion Criteria:

  • Haemodynamically significant heart disease;
  • Restrictive lung disease;
  • Congenital metabolic disease;
  • Mentally retarded;
  • Bariatric surgery;
  • Diabetes type II, dependent on medicine.

Sites / Locations

  • Maastricht University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention group

Control group

Arm Description

The intervention is an integral and multidisciplinary lifestyle intervention consisting of a healthy diet, appropriate physical activity and, if applicable, smoking cessation, customised to the needs of the women.

The control group will receive usual care, including standard lifestyle advices during consultation with the GP, midwife, obstetrician or at the child well being centre. Furthermore, the control group will receive 1 recipe for a healthy meal per week.

Outcomes

Primary Outcome Measures

Reduction in body weight

Secondary Outcome Measures

Gestational weight gain
Postpartum weight retention
Smoking cessation
Biochemical verification of tobacco use
The amount of carbon monoxice (CO) in exhaled breath will be measured using a CO monitor (piCO Baby Smokerlyzer®, Bedfont, Kent, United Kingdom). Biochemical verification will also be done by measurement of urine cotinine.
Dietary habits
By a food diary and the three factor eating questionnaire.
Physical activity habits
By an accelerometer and the Baecke questionnaire.
Miscarriage
Time to pregnancy
Pregnancy complications
Gestational diabetes mellitus, pregnancy-induced hypertension, preeclampsia.
Delivery complications
Caesarean section, induction of labour, vacuum extraction, postpartum haemorrhage, maternal hospital stay, shoulder dystocia.
Vitamin D status
Dysmaturity and macrosomia
Prematurity
Birth before 37 weeks of gestational age
Fasting glucose level
Fasting insulin level
Insuline resistance (HOMA-IR)
Total cholesterol
LDL cholesterol
HDL cholesterol
Triglycerides
Free fatty acids
Alkaline phosphatase
Gamma-GT
ASAT
ALAT
Blood pressure
Pulse wave velocity
Fat mass and fatt free mass
Body composition will be measured using the deuterium dilution method
Fasting glucose level of the child
Fasting insulin level of the child
Insulin resistance (HOMA-IR) of the child
Total cholesterol of the child
LDL cholesterol of the child
HDL cholesterol of the child
Triglycerides of the child
Free fatty acids of the child
Tidal volume of the child
Respiratory rate of the child
Respiratory system resistance of the child
Respiratory system reactance of the child
Endothelial vasodilatation of the child: Percentage change between baseline and maximum perfusion acetylcholine
Endothelial vasodilatation of the child: Percentage change between baseline and maximum perfusion nitroprusside

Full Information

First Posted
February 25, 2016
Last Updated
July 15, 2020
Sponsor
Maastricht University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02703753
Brief Title
TOP-mums, for a Healthy Start
Official Title
TOwards Prepared Mums (TOP-mums), for a Healthy Start: A Lifestyle Intervention to Reduce Overweight and Smoking in Women With a Pregnancy Wish to Prevent Perinatal Morbidity
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
July 27, 2016 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maastricht University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effect of a lifestyle intervention for women with a pregnancy wish who have a high risk on perinatal morbidity because of overweight or obesity. Half of the patients will receive the lifestyle intervention while the other half will receive usual care. It is hypothesized that an effective lifestyle intervention directed towards healthy living, including reduction of overweight or obesity and, if applicable, smoking reduction, health problems in mothers and their offspring can be prevented.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight, Obesity, Pregnancy Complications

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
112 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
The intervention is an integral and multidisciplinary lifestyle intervention consisting of a healthy diet, appropriate physical activity and, if applicable, smoking cessation, customised to the needs of the women.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The control group will receive usual care, including standard lifestyle advices during consultation with the GP, midwife, obstetrician or at the child well being centre. Furthermore, the control group will receive 1 recipe for a healthy meal per week.
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle intervention
Intervention Description
The investigational treatment consists of a lifestyle intervention targeting on a healthy diet, physical activity and, if applicable, smoking cessation.
Primary Outcome Measure Information:
Title
Reduction in body weight
Time Frame
From baseline to 6 weeks postpartum
Secondary Outcome Measure Information:
Title
Gestational weight gain
Time Frame
6 weeks of gestational age to 36 weeks of gestational age
Title
Postpartum weight retention
Time Frame
6 weeks of gestational age to 6 months postpartum
Title
Smoking cessation
Time Frame
Baseline. Prepregnancy: after 1, 2, 3, 6, 9 and 12 months. During pregnancy: at 6,12,20,32,36 and 40 weeks of gestational age. Postpartum: at 6 weeks and at 3, 6, 9 and 12 months.
Title
Biochemical verification of tobacco use
Description
The amount of carbon monoxice (CO) in exhaled breath will be measured using a CO monitor (piCO Baby Smokerlyzer®, Bedfont, Kent, United Kingdom). Biochemical verification will also be done by measurement of urine cotinine.
Time Frame
Baseline. Prepregnancy: after 1, 2, 3, 6, 9 and 12 months. During pregnancy: at 6,12,20,32,36 and 40 weeks of gestational age. Postpartum: at 6 weeks and at 3, 6, 9 and 12 months.
Title
Dietary habits
Description
By a food diary and the three factor eating questionnaire.
Time Frame
Baseline. Prepregnancy: after 3 and 12 months. During pregnancy: at 6 and 32 weeks of gestational age. Postpartum: 3 and 12 months.
Title
Physical activity habits
Description
By an accelerometer and the Baecke questionnaire.
Time Frame
Baseline. Prepregnancy: after 3 and 12 months. During pregnancy: at 6 and 32 weeks of gestational age. Postpartum: 3 and 12 months.
Title
Miscarriage
Time Frame
During pregnancy: at 6, 12 and 20 weeks of gestational age.
Title
Time to pregnancy
Time Frame
From pregnancy wish to first day of last menstruation
Title
Pregnancy complications
Description
Gestational diabetes mellitus, pregnancy-induced hypertension, preeclampsia.
Time Frame
At birth
Title
Delivery complications
Description
Caesarean section, induction of labour, vacuum extraction, postpartum haemorrhage, maternal hospital stay, shoulder dystocia.
Time Frame
At birth
Title
Vitamin D status
Time Frame
Will be measured at baseline and at 32 weeks of gestational age.
Title
Dysmaturity and macrosomia
Time Frame
At birth
Title
Prematurity
Description
Birth before 37 weeks of gestational age
Time Frame
At birth
Title
Fasting glucose level
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Fasting insulin level
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Insuline resistance (HOMA-IR)
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Total cholesterol
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
LDL cholesterol
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
HDL cholesterol
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Triglycerides
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Free fatty acids
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Alkaline phosphatase
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Gamma-GT
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
ASAT
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
ALAT
Time Frame
Will be measured at baseline; Prepregnancy: after 3 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: 3, 6 and 12 months.
Title
Blood pressure
Time Frame
Will be measured at baseline; Prepregnancy: after 1, 2, 3, 6, 9 and 12 months; During pregnancy: at 6, 12, 20, 32, 36 and 40 weeks of gestational age; Postpartum: at 6 weeks and at 3, 6, 9 and 12 months.
Title
Pulse wave velocity
Time Frame
Will be measured at baseline; Prepregnancy: after 3, 6 and 12 months; During pregnancy: at 6, 20 and 32 weeks of gestational age; Postpartum: at 6 and 12 months.
Title
Fat mass and fatt free mass
Description
Body composition will be measured using the deuterium dilution method
Time Frame
Will be measured at baseline, at 32 weeks of gestational age during pregnancy and 6 months postpartum
Title
Fasting glucose level of the child
Time Frame
At birth and 12 months postpartum
Title
Fasting insulin level of the child
Time Frame
At birth and 12 months postpartum
Title
Insulin resistance (HOMA-IR) of the child
Time Frame
At birth and 12 months postpartum
Title
Total cholesterol of the child
Time Frame
At birth and 12 months postpartum
Title
LDL cholesterol of the child
Time Frame
At birth and 12 months postpartum
Title
HDL cholesterol of the child
Time Frame
At birth and 12 months postpartum
Title
Triglycerides of the child
Time Frame
At birth and 12 months postpartum
Title
Free fatty acids of the child
Time Frame
At birth and 12 months postpartum
Title
Tidal volume of the child
Time Frame
Will be measured at 6 weeks and 12 months postpartum
Title
Respiratory rate of the child
Time Frame
Will be measured at 6 weeks and 12 months postpartum
Title
Respiratory system resistance of the child
Time Frame
Will be measured at 6 weeks and 12 months postpartum
Title
Respiratory system reactance of the child
Time Frame
Will be measured at 6 weeks and 12 months postpartum
Title
Endothelial vasodilatation of the child: Percentage change between baseline and maximum perfusion acetylcholine
Time Frame
Will be measured at 6 weeks and 3 and 12 months postpartum
Title
Endothelial vasodilatation of the child: Percentage change between baseline and maximum perfusion nitroprusside
Time Frame
Will be measured at 6 weeks and 3 and 12 months postpartum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women with a pregnancy wish within 1 year; Aged 18-40 years; Overweight/obesity (BMI ≥ 25 kg/m2). Exclusion Criteria: Haemodynamically significant heart disease; Restrictive lung disease; Congenital metabolic disease; Mentally retarded; Bariatric surgery; Diabetes type II, dependent on medicine.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dorien Reijnders, PhD
Phone
+31 683049082
Email
dorien.reijnders@mumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Anita Vreugdenhil, MD, PhD
Phone
+31 43 38 75284
Email
a.vreugdenhil@mumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anita Vreugdenhil, MD, PhD
Organizational Affiliation
Maastricht UMC+
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Luc Zimmermann, Prof, MD
Organizational Affiliation
Maastricht UMC+
Official's Role
Study Chair
Facility Information:
Facility Name
Maastricht University Medical Center
City
Maastricht
State/Province
Limburg
ZIP/Postal Code
6229HX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dorien Reijnders, PhD
Phone
+31683049082
Email
dorien.reijnders@mumc.nl

12. IPD Sharing Statement

Citations:
PubMed Identifier
31748290
Citation
Timmermans YEG, van de Kant KDG, Reijnders D, Kleijkers LMP, Dompeling E, Kramer BW, Zimmermann LJI, Steegers-Theunissen RPM, Spaanderman MEA, Vreugdenhil ACE. Towards Prepared mums (TOP-mums) for a healthy start, a lifestyle intervention for women with overweight and a child wish: study protocol for a randomised controlled trial in the Netherlands. BMJ Open. 2019 Nov 19;9(11):e030236. doi: 10.1136/bmjopen-2019-030236.
Results Reference
derived

Learn more about this trial

TOP-mums, for a Healthy Start

We'll reach out to this number within 24 hrs